Tag: Banned

Tesamorelin, marketed under brand names like Egrifta WR, is not banned and remains an FDA-approved treatment for HIV-associated lipodystrophy. The persistent question of "Why was tesamorelin banned?" stems from regulatory events and confusion surrounding different formulations and international market applications. This article clarifies the drug's true regulatory history.

While Buckley's cough syrup is a Canadian household staple, its distinct product formulations have prevented it from being widely sold in the United States. The perception that Buckley's is "banned" in the US stems from strict regulations by the U.S. Food and Drug Administration (FDA) that target certain ingredients and safety standards, which differ significantly from those enforced by Health Canada. The differences primarily boil down to ingredient approvals and variations in manufacturing and packaging rules.

In 2012, the World Anti-Doping Agency (WADA) officially added desmopressin, a synthetic analog of the hormone vasopressin, to its list of prohibited substances. This decision was primarily driven by its potential use as a masking agent to conceal blood doping practices among athletes.